Newer therapies for Parkinson's disease.
Korczyn
A D
AD
Department of Neurology, Sackler Faculty of Medicine Tel-Aviv University.
Nisipeanu
P
P
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D001971:Bromocriptine / Q000627:therapeutic use; D000077465:Cabergoline; D018491:Dopamine Agonists / Q000627:therapeutic use*; D004873:Ergolines / Q000627:therapeutic use; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*
D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D004873:Ergolines; D007211:Indoles; C046649:ropinirole; D001971:Bromocriptine; D000077465:Cabergoline